Dex-Moxi is a Ophthalmic Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride Monohydrate.
Product ID | 71384-512_638a4320-9c27-4122-e053-2991aa0af758 |
NDC | 71384-512 |
Product Type | Human Prescription Drug |
Proprietary Name | Dex-Moxi |
Generic Name | Dexamethasone Phosphate - Moxifloxacin |
Dosage Form | Injection, Solution |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2018-01-05 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Imprimis NJOF, LLC |
Substance Name | DEXAMETHASONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE |
Active Ingredient Strength | 1 mg/mL; mg/mL |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-01-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-01-05 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-02-10 |
Ingredient | Strength |
---|---|
DEXAMETHASONE SODIUM PHOSPHATE | 1 mg/mL |
SPL SET ID: | 62ff1da3-7998-676a-e053-2991aa0a4a9f |
Manufacturer | |
UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() DEX-MOXI 86852608 5131504 Live/Registered |
HARROW IP, LLC 2015-12-17 |